Radiologists must monitor novel Alzheimer’s treatment side effect, says study

A new article published in RadioGraphics examines the use of monoclonal antibody therapies for treating Alzheimer’s disease and alerts physicians to be on the lookout for a potential side effect: amyloid-related imaging abnormalities (ARIA).

Leave A Comment

Your email address will not be published. Required fields are marked *